The predictive value of the acute effect of montelukast on an exercise challenge test for the outcome of longterm treatment with montelukast.

Trial Profile

The predictive value of the acute effect of montelukast on an exercise challenge test for the outcome of longterm treatment with montelukast.

Completed
Phase of Trial: Phase IV

Latest Information Update: 14 Aug 2014

At a glance

  • Drugs Montelukast (Primary)
  • Indications Allergic asthma; Bronchoconstriction; Exercise-induced asthma
  • Focus Therapeutic Use
  • Acronyms SD-MLK
  • Most Recent Events

    • 13 Jul 2013 Status changed from recruiting to completed as reported by European Clinical Trials Database record
    • 28 Mar 2012 Actual initiaiton date 22 Apr 2010 adde as reported by European Clinical Trials Database.
    • 28 Mar 2012 Status changed from planning to recruiting as reported by European Clinical Trials Database.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top